Cargando…
Effects of the sigma-1 receptor agonist blarcamesine in a murine model of fragile X syndrome: neurobehavioral phenotypes and receptor occupancy
Fragile X syndrome (FXS), a disorder of synaptic development and function, is the most prevalent genetic form of intellectual disability and autism spectrum disorder. FXS mouse models display clinically-relevant phenotypes, such as increased anxiety and hyperactivity. Despite their availability, so...
Autores principales: | Reyes, Samantha T., Deacon, Robert M. J., Guo, Scarlett G., Altimiras, Francisco J., Castillo, Jessa B., van der Wildt, Berend, Morales, Aimara P., Park, Jun Hyung, Klamer, Daniel, Rosenberg, Jarrett, Oberman, Lindsay M., Rebowe, Nell, Sprouse, Jeffrey, Missling, Christopher U., McCurdy, Christopher R., Cogram, Patricia, Kaufmann, Walter E., Chin, Frederick T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8387417/ https://www.ncbi.nlm.nih.gov/pubmed/34433831 http://dx.doi.org/10.1038/s41598-021-94079-7 |
Ejemplares similares
-
A precision medicine framework using artificial intelligence for the identification and confirmation of genomic biomarkers of response to an Alzheimer's disease therapy: Analysis of the blarcamesine (ANAVEX2‐73) Phase 2a clinical study
por: Hampel, Harald, et al.
Publicado: (2020) -
Sigma-1 Receptor Changes Observed in Chronic Pelvic Pain Patients: A Pilot PET/MRI Study
por: Yoon, Daehyun, et al.
Publicado: (2021) -
Retinal Photoreceptor Protection in an AMD-Related Mouse Model by Selective Sigma-1 or Sigma-2 Receptor Modulation
por: Mavlyutov, Timur A., et al.
Publicado: (2022) -
Sigma Receptor Ligands Prevent COVID Mortality In Vivo: Implications for Future Therapeutics
por: Berkowitz, Reed L., et al.
Publicado: (2023) -
Altered Gut Microbiota in a Fragile X Syndrome Mouse Model
por: Altimiras, Francisco, et al.
Publicado: (2021)